Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim F Greten

Showing results (1-10 of 222) with videos related to

Pageof 23
Sort By:
Gut|January 10, 2023
'Invisible' immune checkpoint molecule causing resistance to anti-PD1 therapy in HCCTim F Greten
Gut|March 18, 2014
Myeloid-derived suppressor cells in pancreatic cancer: more than a hidden barrier for antitumour immunity?Tim F Greten
Hepatology (Baltimore, Md.)|February 11, 2018
The ABC of adaptive immunity in liver cancerTim F Greten
The Journal of Experimental Medicine|April 20, 2019
Gender disparity in HCC: Is it the fat and not the sex?Tim F Greten
Cancer Cell|November 15, 2017
Does CSF1R Blockade Turn into Friendly Fire?Tim F Greten
Pharmacology & Therapeutics|February 8, 2017
Tumor regulation of the tissue environment in the liverTobias Eggert, Tim F Greten
Gut|October 26, 2017
CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCCTim F Greten, Firouzeh Korangy
Journal of Hepatology|September 20, 2017
Targets for immunotherapy of liver cancerTim F Greten, Bruno Sangro
Hepatic Oncology|December 13, 2017
Cellular senescence associated immune responses in liver cancerTim F Greten, Tobias Eggert
Die Gastroenterologie|June 11, 2025
[New immunotherapy approaches for gastrointestinal cancer]Bernd Heinrich, Tim F Greten
Pageof 23

Showing results (1-10 of 222) with videos related to

Sort By:
Pageof 23
Gut|January 10, 2023
'Invisible' immune checkpoint molecule causing resistance to anti-PD1 therapy in HCCTim F Greten
Gut|March 18, 2014
Myeloid-derived suppressor cells in pancreatic cancer: more than a hidden barrier for antitumour immunity?Tim F Greten
Hepatology (Baltimore, Md.)|February 11, 2018
The ABC of adaptive immunity in liver cancerTim F Greten
The Journal of Experimental Medicine|April 20, 2019
Gender disparity in HCC: Is it the fat and not the sex?Tim F Greten
Cancer Cell|November 15, 2017
Does CSF1R Blockade Turn into Friendly Fire?Tim F Greten
Pharmacology & Therapeutics|February 8, 2017
Tumor regulation of the tissue environment in the liverTobias Eggert, Tim F Greten
Gut|October 26, 2017
CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCCTim F Greten, Firouzeh Korangy
Journal of Hepatology|September 20, 2017
Targets for immunotherapy of liver cancerTim F Greten, Bruno Sangro
Hepatic Oncology|December 13, 2017
Cellular senescence associated immune responses in liver cancerTim F Greten, Tobias Eggert
Die Gastroenterologie|June 11, 2025
[New immunotherapy approaches for gastrointestinal cancer]Bernd Heinrich, Tim F Greten
Pageof 23